Ozempic Arrives in India: Diabetes Drug Sparks Weight Loss Buzz

Ozempic, a once-weekly injectable medication developed for Type 2 diabetes management, has recently become available in India. This arrival marks a significant advancement, though medical experts are urging careful application under professional guidance. The drug has shown consistent efficacy in lowering blood sugar and maintaining glycemic control with a minimal risk of hypoglycemia since its global approval in 2017.

Globally, Ozempic's notable side effect of weight loss has fueled considerable interest, particularly among individuals managing obesity linked to diabetes or metabolic disorders. Primarily prescribed for adults with Type 2 diabetes who are overweight or have insufficient control with oral medications, it may also be considered for weight management with stringent medical oversight. It is crucial to understand that Ozempic is not intended for aesthetic purposes or casual weight loss.

Beyond its primary function, Ozempic offers kidney protection, with clinical trials indicating a nearly 24% reduction in the progression of kidney disease in diabetic patients. However, its use requires meticulous initiation and monitoring by trained specialists. Contraindications include a history of certain thyroid cancers or pancreatitis, and common side effects like nausea and digestive issues usually subside with proper titration and lifestyle adjustments.